The Scientist

» addiction, genetics & genomics and immunology

Most Recent

image: Contributors

Contributors

By | November 1, 2017

Meet some of the people featured in the November 2017 issue of The Scientist.

0 Comments

image: Infographic: Understanding Our Diverse Brain

Infographic: Understanding Our Diverse Brain

By , , and | November 1, 2017

Recent advances in single-cell omics and other techniques are revealing variation at genomic, epigenomic, transcriptomic, and posttranscriptomic levels.

0 Comments

image: Kyle Smith Shines a Light on Addiction

Kyle Smith Shines a Light on Addiction

By | November 1, 2017

The Dartmouth College professor uses optogenetics to probe the neurological routes of habitual behavior.

0 Comments

image: Lessons in Memory from a Champ

Lessons in Memory from a Champ

By | November 1, 2017

A four-time winner of the USA Memory Championship is helping scientists understand how the brain works.

1 Comment

image: Advancing Techniques Reveal the Brain’s Impressive Diversity

Advancing Techniques Reveal the Brain’s Impressive Diversity

By , , and | November 1, 2017

No two neurons are alike. What does that mean for brain function?

1 Comment

With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans.

1 Comment

image: RNA Editing Possible with CRISPR-Cas13

RNA Editing Possible with CRISPR-Cas13

By | October 25, 2017

Scientists extend the capabilities of the CRISPR-Cas system to include precise manipulations of RNA sequences in human cells.

3 Comments

image: Genetic Risk Factors for Breast Cancer Identified

Genetic Risk Factors for Breast Cancer Identified

By | October 23, 2017

Researchers identify 72 novel genetic variants associated with breast cancer risk.

0 Comments

Professionals in the genetics field generally support editing the genomes of somatic cells, mirroring public opinion, but diverge from nonexperts when it comes to germline editing.

1 Comment

image: FDA Approves Second CAR T-Cell Therapy

FDA Approves Second CAR T-Cell Therapy

By | October 19, 2017

The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 

0 Comments

Popular Now

  1. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Antiviral Immunotherapy Comes of Age
    News Analysis Antiviral Immunotherapy Comes of Age

    T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

  4. Search for Life on the Red Planet
FreeShip